Customers in multiple countries want to cooperate with us

At this year's CPhI China 2019 exhibition, Chongqing Asincan Biotech Co.,Ltd has brought new and characteristic products. Customers from Europe, the United States, Argentina, Brazil, Japan, India, Bangladesh, Pakistan, Egypt, Russia, Mexico, South Korea, Malaysia, Indonesia, Iran, the United Arab Emirates, China and other countries interviewed with us and had express their willingness to cooperate with us at the exhibition.           

Main products of our company are:           

Delafloxacin Meglumine: global leading product, we are planning to register in China;           

Elagolix Sodium: sale to global markets, we are planning to register in China, the United States, Europe, Japan, Brazil, South Korea and Mexico;           

Tedizolid Phosphate, Carfilzomib: China leading product, we are planning to register in China;           

Apremilast, Rivaroxaban, Obeticholic Acid, Palbociclib, Tofacitinib Citrate: it has advantages in cost and quality, we are planning to register in China;           

Iron Sucrose: it has advantage in quality;           

APIs list

Our company has rich experience in API R&D, strong API R&D capability, high-level GMP cooperative factories, global service capabilities. We can provide a large amount of API ingredients, with the ability to undertake CMC, CMO and CDMO. At the same time, our company has a wide range of sales channels and operational capabilities, we are willing to launch in-depth cooperation with more R&D enterprises, manufacturers and investment companies. We have a positive and effective incentive mechanism to ensure efficient and rapid development of a large amount of new products. Our factory has got NMPA, WHO, PMDA, FDA and GMP certification.

R&D center analytical laboratory

Chongqing Asincan Biotech Co.,Ltd

API factory

CHONGQING ASINCAN BIOTECH CO., LTD.(here in after referred to as the company) is mainly engaged in the R&D and operation of APIs and pharmaceuticals. The company has experienced R&D team; R&D personnel have been engaged in drug research and development for many years, have done a number of generic and innovative drug research and development; R&D center and a number of research and development institutes close cooperation, with LC-MASS, GC-MASS, XRD, HPLC, UV, IR and other research and development of common analytical equipment.